Reports Spur Lawmakers To Call For End To Avandia

Law360, New York (June 29, 2010, 5:20 PM EDT) -- On the heels of two new Journal of the American Medical Association reports linking GlaxoSmithKline PLC's Avandia to stroke and heart failure, lawmakers have again called for the U.S. Food and Drug Administration to knock the diabetes drug off pharmacy shelves.

“Coupled with the previous findings, these new studies appear to confirm that Avandia is dangerous and should be pulled from the market,” Rep. Rosa DeLauro, D-Conn., said in a statement.

One of the JAMA reports found that rosiglitazone, the key ingredient in Avandia, was associated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.